
Procyon Corporation
Share · US7428063009 (OTC)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Procyon Corporation
No Price
Closing Price OTC 28.04.2026:
0,20 USD
28.04.2026 20:00
Current Prices from Procyon Corporation
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
UTC |
PCYN
|
USD
|
28.04.2026 20:00
|
0,20 USD
| 0,00 USD |
Company Profile for Procyon Corporation Share
Procyon Corporation, together with its subsidiaries, develops and markets proprietary medical products for use in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems primarily in the United States. The company offers advanced skin and wound care products, including the hydrogel wound dressing products, post op surgical kits, saline wound washes, care lotions, and barrier lotions to promote healing in wound and problematic skin conditions, as well as hand sanitizer under the AMERIGEL brand name. It also provides Bioactive Collagen products in the form of power and matrix under the HELIX3 brand name. In addition, the company offers wound care products, such as calcium alginate, foam, gauze, and hyrdocolloid dressing products; and wound care kits, which include calcium alginate, collagen matrix, collagen powder, foam, and hydrogel wound care kits under the AMERX brand name, as well as compression garment line products under the EXTREMIT-EASE name. It sells its products through distributors to institutional customers, such as hospitals, wound care clinics, nursing homes, home health agencies, physicians, and health care practitioners; and retail customers through direct sales, and internet sales, as well as through independent and retail chain drug stores. The company was incorporated in 1987 and is based in Clearwater, Florida.
Company Data
Name Procyon Corporation
Company Procyon Corporation
Website
https://procyoncorp.com
Primary Exchange
UTC
ISIN US7428063009
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Justice W. Anderson
Country United States of America
Currency USD
Employees 0,0 T
Address 1300 South Highland Avenue, 33756 Clearwater
IPO Date 1996-12-11
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | PCYN |
More Shares
Investors who hold Procyon Corporation also have the following shares in their portfolio:

